Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Ensysce Biosciences announced it raised $77.2 Million in an initial filing from an offering of $77.2 Million
PUBLIC · ENSCAug 20, 2026•1 day ago
Amount Raised
$77.2 Million
Round Type
Venture - Series Unknown
La JollaBiotechnologyHealthcare
Company Information
Company
Ensysce Biosciences
Location
7946 IVANHOE AVE
La Jolla, California, United States
About
Ensysce Biosciences, Inc. (NASDAQ: ENSC) is a clinical-stage biotech company developing a new class of prescription drugs that will provide patients and prescribers safer options for the use of potent prescription drugs, reducing abuse and preventing overdoses.
Don't miss Ensysce Biosciences's next move
Get an email the moment Ensysce Biosciences raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
1 contact
Verified contacts8 people are listed at Ensysce Biosciences. We don't have their email yet.
Predictive Intelligence
Strategic
ML-powered predictions for Ensysce Biosciences's next move
La JollaBiotechnologyHealthcare